LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Method Identifies Anthrax Bacteria Faster Than Current Approaches

By LabMedica International staff writers
Posted on 06 Mar 2014
Caption: The anthrax bacteria – Bacillus anthracis, transmitted mainly through inhalation or skin abrasions (Photo courtesy of University of Missouri).
Caption: The anthrax bacteria – Bacillus anthracis, transmitted mainly through inhalation or skin abrasions (Photo courtesy of University of Missouri).
A new method has been developed for rapid diagnostic detection and antibiotic susceptibility determination of the pathogenic Bacillus anthracis using a bioluminescent reporter phage.

Although anthrax is a treatable disease, positive patient prognosis is dependent on rapid diagnosis and therapy. A team at the University of Missouri (MU; Columbia, MO, USA) assessed a bioluminescent reporter phage, developed by David Schofield at Guild BioSciences (Charleston, SC, USA), for its value as a clinical diagnostic tool for Bacillus anthracis. The reporter phage based method, published in the Journal of Microbiological Methods (November 2013), detects live B. anthracis strains by transducing a bioluminescent phenotype. It was found to rule out false positives – displaying species specificity by its inability, or significantly reduced ability, to detect members of the closely related Bacillus cereus group and other common bacterial pathogens.

The method detects low levels of B. anthracis, at clinically relevant bacterial concentrations, within 5 hours. “Normally to identify whether an organism is present, you have to extract the material, culture it, and then pick colonies to examine that might turn out to be anthrax bacteria,” said Prof. George Stewart, PhD, medical bacteriologist. “Then you conduct chemical testing which takes some time—a minimum of 24 to 48 hours. Using this newly-identified method, we can reduce that time to about 5 hours.” The method also provides antibiotic susceptibility information that mirrors the CLSI method, except that data are obtained at least 5-fold faster.

In addition to saving lives, the new method could also save on high clean up and decontamination costs of bioterrorism attacks. These costs for the post-9/11 2001 anthrax letters attack totaled USD 3.2 million, according to a 2012 report. “In the years since the post-9/11 postal attacks, we haven’t had any bona fide anthrax attacks,” said Prof. Stewart; “That doesn’t mean that it’s not going to happen, we just have to be prepared.” Current methods take 1–3 days to produce definitive results for anthrax. The new detection method would potentially alert of a negative result 5 hours into clean-up efforts instead of 1–3 days into expensive decontamination.

Related Links:
University of Missouri at Columbia
Guild Biosciences

Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Gold Member
Collection and Transport System
PurSafe Plus®

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more